Wikisage, the free encyclopedia of the second generation, is digital heritage
Primidone: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 8: | Line 8: | ||
<ref>https://www.ncbi.nlm.nih.gov/pubmed/27843822 Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner </ref> | <ref>https://www.ncbi.nlm.nih.gov/pubmed/27843822 Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner </ref> | ||
==Links== | ==Links== | ||
http://www.jle.com/download/epd-303433-interactions_between_antiepileptic_drugs_and_between_antiepileptic_drugs_and_other_drugs--WDhqcX8AAQEAAG@xeO4AAAAJ-a.pdf Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs | |||
[http://www.jle.com/download/epd-303433-interactions_between_antiepileptic_drugs_and_between_antiepileptic_drugs_and_other_drugs--WDhqcX8AAQEAAG@xeO4AAAAJ-a.pdf Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs] | |||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242891/pdf/11606_2014_Article_2907.pdf Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242891/pdf/11606_2014_Article_2907.pdf Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications] | ||
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
Revision as of 17:21, 25 November 2016
historical considered a prodrug of phenobarbital, nevertheless it is superior against tremor [1] [2] Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner
ATC
Links
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs
Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications
Notes
- ↑ Essential Tremor: What We Can Learn from Current Pharmacotherapy
- ↑ Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/27843822 Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner